Aktie 121096 DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Dawnrays Pharmaceutical (Holdings) Limited

Aktien

121096

KYG2687M1006

2348

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:22 10.05.2024 		% 5 Tage % 1. Jan.
1,21 HKD +1,68 % Intraday Chart für Dawnrays Pharmaceutical (Holdings) Limited +3,42 % +15,24 %
26.03. Dawnrays Pharmaceutical (Holdings) Limited schlägt Schlussdividende für das Jahr bis zum 31. Dezember 2023 vor, zahlbar am 12. Juni 2024 CI
25.03. Dawnrays Gewinn fällt 2023 um 9% aufgrund niedrigerer Umsätze MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024
Dawnrays' 2023 Profit Falls 9% on Lower Revenue
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Akeso Unit Buys 35% Stake in Biopharmaceutical Firm from Dawnrays; Akeso Shares Slide 3%
Dawnrays Pharmaceutical Limited Declares Interim Dividend for the Year Ending December 31, 2023, Payable on October 5, 2023
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Dawnrays Pharmaceutical Limited Announces the National Medical Products Administration Accepts the New Drug Application for Ebronucimab Injection
Dawnrays Pharmaceutical Limited Approves Final Dividend for the Year Ended 31 December 2022
Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 13 June 2023
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Dawnrays Pharmaceutical Unit to Provide $14.4 Million Loan to AD Pharmaceuticals
Dawnrays Pharmaceutical Limited(SEHK:2348) dropped from S&P Global BMI Index
Dawnrays Pharmaceutical Limited Announces Interim Semi-Annual Ordinary Dividend for the Six Months Ended 30 June 2022, Payable on 05 October 2022
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Dawnrays Pharmaceutical Limited Declares Final Dividend for the Year Ended December 31, 2021
Dawnrays Pharmaceutical Limited Proposes to Declare Final Dividend for the Year Ended December 31, 2021
Dawnrays Pharmaceutical Limited Announces Final Dividend for the Year Ended 31 December 2021, Payable on 15 June 2022
Dawnrays Pharmaceutical Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Dawnrays Pharma CEO Resigns
Dawnrays Pharmaceutical Limited Announces Resignation of Chen Shaojun as Executive Director, Effective February 16, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 121096 Aktie
  4. Nachrichten Dawnrays Pharmaceutical (Holdings) Limited
  5. Andere Sprachen